Table 2. Cell lines exposed to BSE or vCJD or normal bovine or human brain suspension and bioassayed in TgBo mice*.
| Cell line |
No. mice | dpi |
No. mice | dpi |
| BSE | NB | vCJD | NB | |||
|---|---|---|---|---|---|---|
| CHO | 21 | 9 | 720 | 17 | 9 | 730 |
| Vero | 20 | 10 | 730 | ND | ND | ND |
| WI-38 | 23 | 10 | 730 | ND | ND | ND |
| R9ab | 18 | 9 | 630 | ND | ND | ND |
| MDCK | 19 | 10 | 730 | 20 | 10 | 730 |
| HEK-293 | 20 | 20 | 730 | ND | ND | ND |
| Mo3F4-3T3 | 17 | 10 | 750 | ND | ND | ND |
*BSE, bovine spongiform encephalopathy; vCJD, variant Creutzfeldt-Jakob disease; NB, normal brain; dpi, days postinculation at cull; ND, not done; CHO, Chinese hamster ovary; Vero, African green monkey kidney; WI-38, human lung diploid fibroblasts; R9ab, rabbit fibroblasts; MDCK, dog kidney; HEK-293, human embryonic kidney; Mo3F4-3T3, mouse fibroblasts.